| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |